Zfhx3 is Essential for Progesterone/progesterone Receptor Signaling to Drive Ductal Side-branching and Alveologenesis in Mouse Mammary Glands
Overview
Authors
Affiliations
Progesterone (Pg)/progesterone receptor (PR) signaling drives mammary gland side-branching and alveologenesis, but the mechanisms through which Pg/PR signaling functions remain to be clarified. Using in vitro and in vivo models and histological and molecular analyses, we determined the role of Zfhx3 transcription factor in mammary gland development driven by Pg/PR signaling. Postnatal deletion of Zfhx3 in mouse mammary epithelial cells attenuated side-branching morphogenesis and alveologenesis. These effects were undetectable in the absence of Pg/PR signaling. During the estrus cycle, Zfhx3 expression corresponded to that of Pg, being at the highest level at the diestrus stage; Zfhx3 deletion inhibited mammary gland branching more potently at diestrus than estrus stage. Loss of Zfhx3 not only attenuated the expansion of stem/progenitor cells driven by Pg/PR signaling, but also impaired the function of Pg/PR signaling in the transcriptional activation of multiple genes. In addition, Pg/PR signaling significantly expanded PR- and Zfhx3-positive epithelial cells, and induced the physical association of ZFHX3 with PR. These findings establish Zfhx3 as an integral transcription factor of Pg/PR signaling in driving side-branching and alveologenesis during mammary gland development.
Gomez G, Udayakumar A, Pourteymoor S, Dennis G, Xing W, Mohan S Calcif Tissue Int. 2024; 115(4):445-454.
PMID: 39085428 PMC: 11648307. DOI: 10.1007/s00223-024-01265-6.
ZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated mA demethylation.
Hu Q, Yin J, Zhao S, Wang Y, Shi R, Yan K Cell Death Discov. 2024; 10(1):284.
PMID: 38871709 PMC: 11176170. DOI: 10.1038/s41420-024-02060-w.
Perez Baca M, Jacobs E, Vantomme L, LeBlanc P, Bogaert E, Dheedene A Am J Hum Genet. 2024; 111(3):509-528.
PMID: 38412861 PMC: 10940049. DOI: 10.1016/j.ajhg.2024.01.013.
Li M, Zheng Y, Li X, Shen X, Zhang T, Weng B BMC Cancer. 2022; 22(1):1280.
PMID: 36476423 PMC: 9727999. DOI: 10.1186/s12885-022-10380-2.
Fu X, Zhang Z, Liu M, Li J, A J, Fu L J Cell Mol Med. 2021; 26(3):800-812.
PMID: 34953044 PMC: 8817138. DOI: 10.1111/jcmm.17125.